Position in MYGN
as of Jun 30, 2026
· filed Jul 31, 2026
Position Value
$7,474,007
+$2,477,189 QoQ
Shares Held
1,308,933
+17.9% QoQ
Ownership
1.37%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#22
of 196 holders
Holding Since
Jun 2025
5 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in MYGN Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026Aberdeen Group plc holds $1,035,545,424 across 24 Diagnostics & Research names. MYGN ranks #19 (0.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | DHR |
Danaher Corp /De/
|
1,339,185 | $255,087,958 | |
| 2 | TMO |
Thermo Fisher Scientific Inc.
|
461,039 | $231,146,511 | |
| 3 | ICLR |
Icon PLC
|
394,362 | $68,504,622 | |
| 4 | WAT |
Waters Corp /De/
|
138,104 | $51,794,522 | |
| 5 | PSNL |
Personalis, Inc.
|
3,747,290 | $50,213,686 | |
| 6 | IDXX |
Idexx Laboratories Inc /De
|
91,286 | $48,056,601 | |
| 7 | IQV |
Iqvia Holdings Inc.
|
238,810 | $46,142,867 | |
| 8 | A |
Agilent Technologies, Inc.
|
288,030 | $38,259,024 |
All Filings in MYGN
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $7,474,007 | 1,308,933 | Shares | Defined | 2026-07-31 | |
| 2026-03-31 | $4,996,818 | 1,110,404 | Shares | Defined | 2026-04-29 | |
| 2025-12-31 | $5,447,676 | 885,801 | Shares | Defined | 2026-01-16 | |
| 2025-09-30 | $4,620,353 | 639,053 | Shares | Defined | 2025-11-07 | |
| 2025-06-30 | $1,219,138 | 229,593 | Shares | Defined | 2025-07-24 | |
| No filing history on record for this holder in this stock. | ||||||